Reviews
Cancer guideline adherence is linked to better overall survival, review finds
Ismaila et alClinical and Public Health Guidelines
A systematic review and meta-analysis evaluated the association between adherence to clinical practice guidelines (CPGs) and clinical outcomes among patients with cancer. Searching five electronic databases through , researchers included 75 studies comprising randomized controlled trials, prospective cohorts, and retrospective cohorts that compared CPG-adherent care against non-adherent management. Target outcomes included overall survival (OS), disease-free survival (DFS), and quality of life, with pooled analyses performed via random-effects modeling and certainty of evidence graded via GRADE methodology.
Pooled results demonstrated that guideline adherence was significantly associated with superior overall survival across all cancer sites (HR = 0.64, 95% CI: 0.59 to 0.70; p < 0.0001, I² = 97%; low certainty of evidence). Site-specific subgroup evaluations yielded comparable findings across most malignancies, such as breast cancer studies with an average 5-year follow-up (HR = 0.70, 95% CI: 0.64 to 0.77; p < 0.001, I² = 0%; low certainty of evidence). However, gynecological cancers diverged, showing no statistically significant difference in OS between adherent and non-adherent groups (HR = 0.76, 95% CI: 0.53 to 1.08; p = 0.13, I² = 77%; low certainty of evidence).
The study notes that existing evidence is primarily derived from retrospective observational designs with high heterogeneity in the primary analysis, underscoring the necessity for prospective trials to validate these findings and guide oncology practice.
Key Takeaways
- Adherence to clinical practice guidelines was associated with significantly improved overall survival across all oncologic sites (HR = 0.64; 95% CI: 0.59 to 0.70; p < 0.0001; low certainty of evidence), including breast cancer cohorts with 5-year follow-up (HR = 0.70; 95% CI: 0.64 to 0.77; p < 0.001).
- Subgroup analysis demonstrated no statistically significant overall survival improvement associated with guideline adherence in gynecological cancers (HR = 0.76; 95% CI: 0.53 to 1.08; p = 0.13; low certainty of evidence).
Read the original sourceClinical and Public Health Guidelines
